1,1-dichloroethene decreases expression ISO RGD:10850 6480464 vinylidene chloride results in decreased expression of L1CAM mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:10850 6480464 ethylene dichloride results in increased expression of L1CAM mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:10850 6480464 1, 2-Dimethylhydrazine results in increased expression of L1CAM mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1352608 6480464 Estradiol results in decreased expression of L1CAM mRNA CTD PMID:16474171 , PMID:19167446 17beta-estradiol multiple interactions ISO RGD:1352608 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of L1CAM mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:1352608 6480464 Estradiol results in increased expression of L1CAM mRNA CTD PMID:31646340 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:10850 6480464 Trinitrobenzenesulfonic Acid results in increased expression of L1CAM mRNA CTD PMID:17982090 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1352608 6480464 2 more ... CTD PMID:26705709 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10850 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of L1CAM mRNA CTD PMID:20188158 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of L1CAM mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1352608 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of L1CAM gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression ISO RGD:10850 6480464 Fenretinide results in decreased expression of L1CAM mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1352608 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of L1CAM mRNA] CTD PMID:21095227 5-fluorouracil decreases expression ISO RGD:1352608 6480464 Fluorouracil results in decreased expression of L1CAM protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:1352608 6480464 L1CAM protein affects the susceptibility to Fluorouracil CTD PMID:15352031 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of L1CAM mRNA CTD PMID:24780913 acrylamide decreases expression ISO RGD:1352608 6480464 Acrylamide results in decreased expression of L1CAM mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1352608 6480464 Aflatoxin B1 results in increased methylation of L1CAM intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1352608 6480464 aflatoxin B2 results in increased methylation of L1CAM intron CTD PMID:30157460 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of L1CAM mRNA CTD PMID:20488242 all-trans-retinoic acid decreases expression ISO RGD:1352608 6480464 Tretinoin results in decreased expression of L1CAM mRNA CTD PMID:34742744 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of L1CAM mRNA CTD PMID:30779732 antimycin A decreases expression ISO RGD:1352608 6480464 Antimycin A results in decreased expression of L1CAM mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:1352608 6480464 aristolochic acid I results in decreased expression of L1CAM mRNA, aristolochic acid I results in decreased expression of L1CAM protein CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:10850 6480464 arsenite results in increased expression of L1CAM mRNA CTD PMID:33053406 arsenite(3-) increases expression ISO RGD:1352608 6480464 arsenite results in increased expression of L1CAM mRNA CTD PMID:31646340 atrazine increases expression ISO RGD:1352608 6480464 Atrazine results in increased expression of L1CAM mRNA CTD PMID:22378314 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of L1CAM mRNA CTD PMID:36841081 azoxystrobin decreases expression ISO RGD:1352608 6480464 azoxystrobin results in decreased expression of L1CAM mRNA CTD PMID:33512557 benzo[a]pyrene increases methylation ISO RGD:1352608 6480464 Benzo(a)pyrene results in increased methylation of L1CAM exon, Benzo(a)pyrene results in increased methylation of L1CAM promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1352608 6480464 Benzo(a)pyrene affects the methylation of L1CAM 3' UTR, Benzo(a)pyrene affects the methylation of L1CAM intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1352608 6480464 7 more ... CTD PMID:20018196 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1352608 6480464 Diethylhexyl Phthalate results in increased expression of L1CAM mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA CTD PMID:31199487 bisphenol A increases expression ISO RGD:10850 6480464 bisphenol A results in increased expression of L1CAM mRNA CTD PMID:16902998 bisphenol A decreases expression ISO RGD:10850 6480464 bisphenol A results in decreased expression of L1CAM mRNA CTD PMID:25594700 , PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of L1CAM mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1352608 6480464 bisphenol A results in decreased expression of L1CAM mRNA CTD PMID:16474171 butanal increases expression ISO RGD:1352608 6480464 butyraldehyde results in increased expression of L1CAM mRNA CTD PMID:26079696 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA CTD PMID:31199487 cadmium atom increases expression ISO RGD:1352608 6480464 Cadmium results in increased expression of L1CAM mRNA CTD PMID:31646340 cadmium atom multiple interactions ISO RGD:10850 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of L1CAM mRNA CTD PMID:36114956 cadmium atom multiple interactions ISO RGD:1352608 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of L1CAM mRNA CTD PMID:31738976 cadmium dichloride multiple interactions ISO RGD:1352608 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of L1CAM mRNA CTD PMID:31738976 cadmium dichloride multiple interactions ISO RGD:10850 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of L1CAM mRNA CTD PMID:36114956 captan decreases expression ISO RGD:10850 6480464 Captan results in decreased expression of L1CAM mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1352608 6480464 Carbamazepine affects the expression of L1CAM mRNA CTD PMID:25979313 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of L1CAM mRNA CTD PMID:18668222 choline multiple interactions ISO RGD:10850 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of L1CAM mRNA CTD PMID:20938992 cisplatin affects response to substance ISO RGD:1352608 6480464 L1CAM affects the susceptibility to Cisplatin CTD PMID:21097529 cisplatin decreases expression ISO RGD:1352608 6480464 Cisplatin results in decreased expression of L1CAM mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1352608 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of L1CAM mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:1352608 6480464 [NSC 689534 binds to Copper] which results in increased expression of L1CAM mRNA CTD PMID:20971185 copper atom multiple interactions ISO RGD:10850 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of L1CAM mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1352608 6480464 [NSC 689534 binds to Copper] which results in increased expression of L1CAM mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:10850 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of L1CAM mRNA CTD PMID:15467011 coumestrol multiple interactions ISO RGD:1352608 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO RGD:1352608 6480464 Coumestrol results in decreased expression of L1CAM mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1352608 6480464 Cyclosporine results in increased expression of L1CAM mRNA CTD PMID:25562108 deguelin decreases expression ISO RGD:1352608 6480464 deguelin results in decreased expression of L1CAM mRNA CTD PMID:33512557 dextran sulfate multiple interactions ISO RGD:10850 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of L1CAM mRNA CTD PMID:29950665 dextran sulfate decreases expression ISO RGD:10850 6480464 Dextran Sulfate results in decreased expression of L1CAM protein CTD PMID:35999755 diallyl trisulfide multiple interactions ISO RGD:1352608 6480464 diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of L1CAM mRNA], diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of L1CAM protein] CTD PMID:28574600 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA CTD PMID:31199487 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA CTD PMID:31199487 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA CTD PMID:31199487 dioxygen multiple interactions ISO RGD:1352608 6480464 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of L1CAM mRNA] more ... CTD PMID:28574600 dioxygen increases expression ISO RGD:1352608 6480464 Oxygen deficiency results in increased expression of L1CAM mRNA, Oxygen deficiency results in increased expression of L1CAM protein CTD PMID:28574600 dorsomorphin multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of L1CAM mRNA, Endosulfan results in decreased expression of L1CAM protein CTD PMID:31464424 Enterolactone multiple interactions ISO RGD:1352608 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of L1CAM mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1352608 6480464 entinostat results in increased expression of L1CAM mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L1CAM mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:10850 6480464 epoxiconazole results in increased expression of L1CAM mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:10850 6480464 Ethanol results in decreased expression of L1CAM mRNA CTD PMID:29018328 ethanol increases expression ISO RGD:10850 6480464 Ethanol results in increased expression of L1CAM mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:10850 6480464 Ethanol affects the expression of L1CAM mRNA CTD PMID:30319688 ethanol increases response to substance ISO RGD:1352608 6480464 L1CAM protein modified form results in increased susceptibility to Ethanol CTD PMID:29109170 ethanol increases response to substance ISO RGD:10850 6480464 L1CAM protein modified form results in increased susceptibility to Ethanol CTD PMID:29109170 ethanol decreases activity ISO RGD:1352608 6480464 Ethanol results in decreased activity of L1CAM protein CTD PMID:8609170 ethanol multiple interactions ISO RGD:1352608 6480464 Ethanol binds to and results in decreased activity of L1CAM protein, Octanols analog inhibits the reaction [Ethanol binds to and results in decreased activity of L1CAM protein] CTD PMID:18165316 , PMID:29109170 fluoxetine multiple interactions EXP 6480464 Ondansetron inhibits the reaction [Fluoxetine results in increased expression of L1CAM protein] CTD PMID:16900104 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of L1CAM protein CTD PMID:16900104 folic acid multiple interactions ISO RGD:10850 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of L1CAM mRNA CTD PMID:20938992 fulvestrant increases expression ISO RGD:1352608 6480464 Fulvestrant results in increased expression of L1CAM mRNA CTD PMID:31646340 genistein decreases expression ISO RGD:1352608 6480464 Genistein results in decreased expression of L1CAM mRNA CTD PMID:16474171 ivermectin decreases expression ISO RGD:1352608 6480464 Ivermectin results in decreased expression of L1CAM protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:10850 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of L1CAM mRNA CTD PMID:20938992 methanol decreases activity ISO RGD:1352608 6480464 Methanol results in decreased activity of L1CAM protein CTD PMID:29109170 methanol increases response to substance ISO RGD:1352608 6480464 L1CAM protein modified form results in increased susceptibility to Methanol CTD PMID:29109170 methylmercury chloride increases expression ISO RGD:1352608 6480464 methylmercuric chloride results in increased expression of L1CAM mRNA CTD PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L1CAM mRNA CTD PMID:27188386 mitomycin C affects response to substance ISO RGD:1352608 6480464 L1CAM protein affects the susceptibility to Mitomycin CTD PMID:16217747 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of L1CAM mRNA CTD PMID:33484710 Ondansetron multiple interactions EXP 6480464 Ondansetron inhibits the reaction [Fluoxetine results in increased expression of L1CAM protein] CTD PMID:16900104 panobinostat multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L1CAM mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1352608 6480464 panobinostat results in increased expression of L1CAM mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:1352608 6480464 Acetaminophen results in decreased expression of L1CAM mRNA CTD PMID:26690555 pentanal increases expression ISO RGD:1352608 6480464 pentanal results in increased expression of L1CAM mRNA CTD PMID:26079696 phenylmercury acetate multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L1CAM mRNA CTD PMID:27188386 picoxystrobin decreases expression ISO RGD:1352608 6480464 picoxystrobin results in decreased expression of L1CAM mRNA CTD PMID:33512557 pirinixic acid decreases expression ISO RGD:10850 6480464 pirinixic acid results in decreased expression of L1CAM mRNA CTD PMID:17426115 potassium chromate increases expression ISO RGD:1352608 6480464 potassium chromate(VI) results in increased expression of L1CAM mRNA CTD PMID:22714537 progesterone decreases expression ISO RGD:1352608 6480464 Progesterone results in decreased expression of L1CAM mRNA CTD PMID:18070364 propanal increases expression ISO RGD:1352608 6480464 propionaldehyde results in increased expression of L1CAM mRNA CTD PMID:26079696 pyrimidifen decreases expression ISO RGD:1352608 6480464 pyrimidifen results in decreased expression of L1CAM mRNA CTD PMID:33512557 resveratrol multiple interactions ISO RGD:1352608 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of L1CAM mRNA CTD PMID:19167446 saracatinib decreases phosphorylation ISO RGD:1352608 6480464 saracatinib results in decreased phosphorylation of L1CAM protein CTD PMID:29109170 SB 431542 multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1352608 6480464 Silicon Dioxide analog results in increased expression of L1CAM mRNA CTD PMID:25895662 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of L1CAM mRNA CTD PMID:32721576 sirolimus affects response to substance ISO RGD:1352608 6480464 L1CAM affects the susceptibility to Sirolimus CTD PMID:21097529 sodium arsenite multiple interactions ISO RGD:1352608 6480464 sodium arsenite results in decreased expression of and affects the splicing of L1CAM mRNA CTD PMID:25879800 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of L1CAM mRNA CTD PMID:35314868 sodium arsenite decreases expression ISO RGD:1352608 6480464 sodium arsenite results in decreased expression of L1CAM mRNA CTD PMID:12016162 , PMID:34032870 tebufenpyrad decreases expression ISO RGD:1352608 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of L1CAM mRNA CTD PMID:33512557 thifluzamide decreases expression ISO RGD:1352608 6480464 thifluzamide results in decreased expression of L1CAM mRNA CTD PMID:33512557 titanium dioxide increases expression ISO RGD:10850 6480464 titanium dioxide results in increased expression of L1CAM mRNA CTD PMID:29128614 , PMID:29264374 titanium dioxide multiple interactions ISO RGD:10850 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of L1CAM mRNA CTD PMID:29950665 trichostatin A increases expression ISO RGD:1352608 6480464 trichostatin A results in increased expression of L1CAM mRNA CTD PMID:24935251 more ... trichostatin A multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L1CAM mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:1352608 6480464 Triclosan results in increased expression of L1CAM mRNA CTD PMID:30510588 Triptolide increases expression EXP 6480464 triptolide results in increased expression of L1CAM protein CTD PMID:32519852 triptonide increases expression ISO RGD:10850 6480464 triptonide results in increased expression of L1CAM mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:10850 6480464 trovafloxacin results in decreased expression of L1CAM mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:1352608 6480464 Valproic Acid affects the expression of L1CAM mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1352608 6480464 Valproic Acid results in decreased expression of L1CAM mRNA CTD PMID:34742744 valproic acid increases expression ISO RGD:1352608 6480464 Valproic Acid results in increased expression of L1CAM mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1352608 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L1CAM mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1352608 6480464 vorinostat results in increased expression of L1CAM mRNA CTD PMID:26272509